Cargando…
The 21-Gene Recurrence Score Assay and Prediction of Chemotherapy Benefit: A Propensity Score-Matched Analysis of the SEER Database
Background: To evaluate the performance of the 21-gene recurrence score (RS) assay in predicting chemotherapy benefit in the Surveillance, Epidemiology, and End Results population, we aimed to assess breast cancer-specific mortality (BCSM) by chemotherapy use within each of the RS categories. Method...
Autores principales: | Choi, In Sil, Jung, Jiwoong, Kim, Byoung Hyuck, Oh, Sohee, Kim, Jongjin, Park, Jin Hyun, Park, Jeong Hwan, Hwang, Ki-Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408834/ https://www.ncbi.nlm.nih.gov/pubmed/32650374 http://dx.doi.org/10.3390/cancers12071829 |
Ejemplares similares
-
Racial differences in predictive value of the 21-gene recurrence score assay: a population-based study using the SEER database
por: Jung, Jiwoong, et al.
Publicado: (2022) -
Validating the ACOSOG Z0011 Trial Result: A Population-Based Study Using the SEER Database
por: Jung, Jiwoong, et al.
Publicado: (2020) -
Survival benefit of active surveillance for papillary thyroid carcinoma: a propensity score matching analysis based on SEER database
por: Bi, Jinzhe, et al.
Publicado: (2023) -
Survival Benefit of Resection Surgery for Pancreatic Ductal Adenocarcinoma with Liver Metastases: A Propensity Score-Matched SEER Database Analysis
por: Pausch, Thomas M., et al.
Publicado: (2021) -
Survival benefit of radiotherapy and nomogram for patients with primary tracheal malignant tumors: a propensity score-matched SEER database analysis
por: Zheng, Zhen, et al.
Publicado: (2023)